Akums Drugs

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE09XN01023
  • NSEID: AKUMS
  • BSEID: 544222
INR
470.30
-28.65 (-5.74%)
BSENSE

Mar 13

BSE+NSE Vol: 2.19 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039335,
    "name": "Akums Drugs",
    "stock_name": "Akums Drugs",
    "full_name": "Akums Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/akums-drugs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "470.30",
    "chg": -28.65,
    "chgp": "-5.74%",
    "dir": -1,
    "prev_price": "498.95",
    "mcapval": "7,678.00 Cr",
    "mcap": "Small Cap",
    "scripcode": "544222",
    "symbol": "AKUMS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE09XN01023",
    "curr_date": "Mar 13",
    "curr_time": "",
    "bse_nse_vol": "2.19 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 13, 2026",
    "traded_date_str": "2026 03 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/akums-drugs-10039335-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Akums Drugs & Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-akums-drugs-pharmaceuticals-ltd-fallingrising-3890419",
        "imagepath": "",
        "date": "2026-03-14 01:19:44",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has been under pressure for the last two consecutive days, losing 7.43% in that period. Today’s intraday low of Rs 469.10 was accompanied by a weighted average price indicating that a larger volume of shares traded near this low, signalling selling pressure. Compared to its sector, Akums underperformed by 4.06% today, reflecting a weaker investor appetite relative to peers. Furthermore, delivery volumes have declined by 14.45% against the five-day average, suggesting reduced investor participation and possibly waning confidence in the short term.</p>\n<p>Technically, the stock price remains above its 50-day and 100-day moving averages, which could be seen as a support level. However, it is trading below its 5-day, 20-day, and ..."
      },
      {
        "title": "Akums Drugs & Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-3882023",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AkumsDrugsPharm_technicaldot_3882023.png",
        "date": "2026-03-10 08:05:29",
        "description": "Akums Drugs & Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest daily price increase, key technical indicators present a mixed picture, signalling caution for investors amid evolving market dynamics in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Akums Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-is-rated-sell-3877866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AkumsDrugsPharm_mojoScore_3877866.png",
        "date": "2026-03-07 10:10:27",
        "description": "Akums Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall market standing."
      },
      {
        "title": "Akums Drugs & Pharmaceuticals Ltd: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-3868422",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AkumsDrugsPharm_technicaldot_3868422.png",
        "date": "2026-03-04 08:07:55",
        "description": "Akums Drugs & Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s price action and momentum oscillators reveal nuanced signals that investors should carefully analyse amid broader market volatility."
      },
      {
        "title": "Akums Drugs Gains 1.96%: 5 Key Technical Shifts Define the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-gains-196-5-key-technical-shifts-define-the-week-3861874",
        "imagepath": "",
        "date": "2026-02-28 09:02:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Feb:</strong> Stock opened at Rs.474.50, down 0.89% amid Sensex gains</p>\n                    <p><strong>24 Feb:</strong> Downgrade to Sell rating announced; stock rebounds +1.81%</p>\n                    <p><strong>25 Feb:</strong> Technical momentum shifts to mildly bullish; price dips -1.06%</p>\n                    <p><strong>26 Feb:</strong> Momentum shifts sideways; stock rises +0.84%</p>\n                    <p><strong>27 Feb:</strong> Mildly bullish momentum confirmed; stock closes at Rs.488.15 (+1.28%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value..."
      },
      {
        "title": "Akums Drugs & Pharmaceuticals Ltd Shows Mildly Bullish Technical Momentum Amid Mixed Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-shows-mildly-bullish-technical-momentum-amid-mixed-returns-3859594",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AkumsDrugsPharm_technicaldot_3859594.png",
        "date": "2026-02-27 08:02:55",
        "description": "Akums Drugs & Pharmaceuticals Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Recent technical indicators, including MACD, Bollinger Bands, and moving averages, reveal a nuanced picture of the stock’s near-term prospects amid mixed sectoral and market returns."
      },
      {
        "title": "Akums Drugs & Pharmaceuticals Ltd Faces Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-faces-technical-momentum-shift-amid-mixed-market-signals-3857393",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AkumsDrugsPharm_technicaldot_3857393.png",
        "date": "2026-02-26 08:03:25",
        "description": "Akums Drugs & Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s price action and technical indicators present a nuanced picture for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Akums Drugs & Pharmaceuticals Ltd: Technical Momentum Shifts Signal Mild Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-3854800",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AkumsDrugsPharm_technicaldot_3854800.png",
        "date": "2026-02-25 08:04:40",
        "description": "Akums Drugs & Pharmaceuticals Ltd has recently exhibited a shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a mixed bag of technical indicators, the stock’s price action and momentum metrics suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Akums Drugs & Pharmaceuticals Downgraded to Sell Amidst Technical and Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-downgraded-to-sell-amidst-technical-and-financial-concerns-3852393",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AkumsDrugsPharm_mojoScore_3852393.png",
        "date": "2026-02-24 08:40:25",
        "description": "Akums Drugs & Pharmaceuticals Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a combination of deteriorating technical indicators, flat financial performance, and subdued growth prospects. The downgrade, effective from 23 February 2026, is driven by a reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals."
      }
    ],
    "total": 174,
    "sid": "10039335",
    "stock_news_url": "https://www.marketsmojo.com/news/akums-drugs-pharmaceuticals-10039335"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Akums Drugs & Pharmaceuticals Ltd falling/rising?

2026-03-14 01:19:44

Recent Price Movement and Market Context

The stock has been under pressure for the last two consecutive days, losing 7.43% in that period. Today’s intraday low of Rs 469.10 was accompanied by a weighted average price indicating that a larger volume of shares traded near this low, signalling selling pressure. Compared to its sector, Akums underperformed by 4.06% today, reflecting a weaker investor appetite relative to peers. Furthermore, delivery volumes have declined by 14.45% against the five-day average, suggesting reduced investor participation and possibly waning confidence in the short term.

Technically, the stock price remains above its 50-day and 100-day moving averages, which could be seen as a support level. However, it is trading below its 5-day, 20-day, and ...

Read full news article

Akums Drugs Gains 1.96%: 5 Key Technical Shifts Define the Week

2026-02-28 09:02:30

Key Events This Week

23 Feb: Stock opened at Rs.474.50, down 0.89% amid Sensex gains

24 Feb: Downgrade to Sell rating announced; stock rebounds +1.81%

25 Feb: Technical momentum shifts to mildly bullish; price dips -1.06%

26 Feb: Momentum shifts sideways; stock rises +0.84%

27 Feb: Mildly bullish momentum confirmed; stock closes at Rs.488.15 (+1.28%)

stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available